Patents by Inventor Collin HEER

Collin HEER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220304977
    Abstract: A method of treating cancer in a subject includes administering an active agent selected from ascorbic acid, an ascorbic acid derivative, and/or a pharmaceutically acceptable salt thereof and administering a pentaaza macrocyclic ring complex corresponding to formula (I) below:
    Type: Application
    Filed: November 30, 2021
    Publication date: September 29, 2022
    Inventors: Robert A. BEARDSLEY, Dennis P. RILEY, Douglas R. SPITZ, JR., Collin HEER, Melissa FATH
  • Patent number: 11219614
    Abstract: A method of treating cancer in a subject includes administering an active agent selected from ascorbic acid, an ascorbic acid derivative, and/or a pharmaceutically acceptable salt thereof and administering a pentaaza macrocyclic ring complex corresponding to formula (I) below:
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: January 11, 2022
    Assignee: Galera Labs, LLC
    Inventors: Robert A. Beardsley, Dennis P. Riley, Douglas R. Spitz, Jr., Collin Heer, Melissa Fath
  • Publication number: 20190209524
    Abstract: A method of treating cancer in a subject includes administering an active agent selected from ascorbic acid, an ascorbic acid derivative, and/or a pharmaceutically acceptable salt thereof and administering a pentaaza macrocyclic ring complex corresponding to formula (I) below:
    Type: Application
    Filed: September 1, 2017
    Publication date: July 11, 2019
    Inventors: Robert A. BEARDSLEY, Dennis P. RILEY, Douglas R. SPITZ, Jr., Collin HEER, Melissa FATH